Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial.

已完结 20 由小满发布于 2026/3/9 14:20:01

DOI:10.4244/EIJV12I10A209
作者：Yaojun Zhang,?Xiaozeng Wang,?G. Fu,?Q. Jing,?Geng Wang,?Chong-ying Jin,?Lihua Xie,?Jin-Zan Cai,?Bo Xu,?Ya‐Ling Han
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：AIMS The study sought to investigate clinical and multimodality imaging assessment of a bioresorbable sirolimus-eluting scaffold (NeoVas, Lepu Medical, Beijing, China) for patients with sing

应助信息

1天前

juan33

17b7e0871b8111f1b57d34735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/3/9 14:20:01 未找到该文献，机器人已退出，请等待人工下载

2026/3/9 14:20:01 Book学术AI机器人收到请求，开始寻找文献

2026/3/9 14:20:01 已向机器人发送请求

1天前

小满发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureA family of large language models for materials research with insights into model adaptability in continued pretraining